Necrotizing Soft Tissue Infection: Clinical Trials

1 trial for Necrotizing Soft Tissue Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Necrotizing Soft Tissue Infection: new trials by email Literature Review of Necrotizing Soft Tissue Infection trials Research Report on Necrotizing Soft Tissue Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Reltecimod 0.5 mg/kg, Placebo - Acute Kidney Injury, Peritonitis
Phase 3TerminatedAtox Bio Ltd582018-05-242021-10-12

Narrower conditions

Acute Kidney Injury (1)  ·  Intraabdominal Infections (1)  ·  Peritonitis (1)

Broader conditions

Digestive System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Infections (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Peritoneal Diseases (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

AB103 (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

Atox Bio Ltd (1)

Countries

France (1)  ·  United States (1)

Top investigators

Azra Bihorac, MD (1)